TWST
Twist Bioscience Corporation · Healthcare · Medical - Diagnostics & Research
Momentum inputs (comparable managers):
holder breadth +7.7% ·
share flow -9.8% ·
net new positions +7.1%
— formula
Ownership fragmentation — more holders, smaller aggregate stake
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 113 | +8 | 54.73M | $5.62B | +14 | −6 |
| Q1 2026 | 108 | +15 | 51.20M | $2.43B | +20 | −5 |
| Q4 2025 | 92 | -2 | 51.46M | $1.63B | +1 | −3 |
| Q3 2025 | 18 | 0 | 32.97M | $927.70M | +1 | −2 |
| Q2 2025 | 16 | -3 | 28.73M | $1.06B | — | −3 |
| Q1 2025 | 16 | +1 | 15.75M | $618.44M | +2 | −1 |
| Q4 2024 | 15 | 0 | 15.20M | $706.21M | — | — |
| Q3 2024 | 14 | +1 | 11.38M | $514.14M | +2 | −1 |
| Q2 2024 | 13 | — | 12.61M | $621.59M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management ✦ | 5.36M | -12.6% | $242.08M | 2.2% | ▼ Trim | 2 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 1.48M | +3.8% | $66.98M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 1.48M | +3.8% | $66.98M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 1.37M | +1.9% | $61.81M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 1.37M | +1.9% | $61.81M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Baillie Gifford ✦ | 834.34K | -15.2% | $37.70M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Baillie Gifford ✦ | 834.34K | -15.2% | $37.70M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | Baillie Gifford ✦ | 834.34K | -15.2% | $37.70M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | Baillie Gifford ✦ | 834.34K | -15.2% | $37.70M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | Wellington Management ✦ | 797.74K | +188.6% | $36.04M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Wellington Management ✦ | 797.74K | +188.6% | $36.04M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Wellington Management ✦ | 797.74K | +188.6% | $36.04M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Wellington Management ✦ | 797.74K | +188.6% | $36.04M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Wellington Management ✦ | 797.74K | +188.6% | $36.04M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | Millennium Management ✦ | 456.01K | -41.7% | $20.60M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 419.59K | -27.6% | $18.96M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Renaissance Technologies ✦ | 214.31K | New | $9.68M | 0.0% | New | 1 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 187.56K | +205.3% | $8.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 187.56K | +205.3% | $8.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 187.56K | +205.3% | $8.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | Norges Bank ✦ (passive) | 183.70K | -23.3% | $8.30M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | T. Rowe Price ✦ | 35.85K | +3.2% | $1.62M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 23 | Gotham Asset Management ✦ | 27.74K | -64.9% | $1.25M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 24 | D. E. Shaw & Co. ✦ | 9.04K | +122.0% | $408,653 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 25 | Marshall Wace ✦ | 5.28K | New | $238,505 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Renaissance Technologies | $9.68M | 0.0% |
| Marshall Wace | $238,505 | 0.0% |
Exited
| Point72 Asset Management | $33.17M | was 0.1% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 279 holders, 76.80M shares, $3.56B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 854 sh · $120,220
Officer · 669 sh · $93,035
Officer · 1.60K sh · $222,227
Officer · 1.97K sh · $273,265
Officer · 1.36K sh · $189,130
Officer · 4.05K sh · $562,661
Officer, Director · 6.64K sh · $923,259
Officer · 14.21K sh · $1.84M
Officer · 2.00K sh · $245,162
Officer · 6.30K sh · $761,860
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology